DOI 10.1016/j.ejphar.2026.178734
Ursolic acid attenuates bone loss by stabilizing osteoblast mitochondrial integrity and inhibiting downstream apoptosis via PI3K-AKT-Bcl2 signaling.
Аннотация
BACKGROUND
The PI3K/AKT signaling pathway is crucial in mitochondrial apoptosis and a core mechanism in the pathogenesis of osteoporosis (OP). Ursolic acid (UA) is a naturally occurring pentacyclic triterpenoid found in various herbal plants that exhibits antioxidant and anti-inflammatory activities and modulates osteoblast function. However, the effects of UA on osteoblast function in OP remain unclear. This study investigated whether UA alleviates mitochondrial damage, inhibits downstream apoptosis, and promotes osteoblast differentiation via the PI3K-AKT pathway.
METHODS
Network pharmacology and molecular docking were used to predict the anti-OP mechanisms of UA. The regulatory effects of UA on the PI3K-AKT axis were evaluated in MC3T3-E1 cells, while its impact on mitochondrial function and osteoblast differentiation was assessed in the presence of LY294002 (PI3K inhibitor) or ABT-737 (Bcl2 inhibitor). The OP mouse model was established via ovariectomy (OVX). Mice received UA (10 or 20 mg/kg/day) or estradiol (0.104 mg/kg/day) as a positive control. Bone microstructure, apoptosis, mitochondrial integrity, and bone metabolism markers were examined.
RESULTS
UA promoted osteoblast differentiation. Network pharmacology and docking identified the PI3K-AKT pathway as a key UA target, which was subsequently validated in vitro. UA mitigated LY294002- or ABT-737-induced mitochondrial damage, alleviated mitochondrial oxidative stress, stabilized mitochondrial membrane potential, and further enhanced osteoblast differentiation. Furthermore, UA attenuated OVX-induced bone loss by restoring PI3K-AKT activity, upregulating Bcl2, improving mitochondrial function, and inhibiting apoptosis.
CONCLUSION
UA promotes osteoblast differentiation and mitigates mitochondrial dysfunction by activating PI3K-AKT-Bcl2 signaling. The findings provide evidence supporting UA as a potential therapeutic candidate for OP.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.